Changes

no edit summary
Line 28: Line 28:  
|-
 
|-
 
|Clonal haematopoiesis||Disease|| || || || || ||Fabiola Quintero-Rivera (FQR)|| ||
 
|Clonal haematopoiesis||Disease|| || || || || ||Fabiola Quintero-Rivera (FQR)|| ||
|NEW DISEASE
+
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 35: Line 35:  
|-
 
|-
 
|Clonal cytopenias of undetermined significance||Disease|| || || || || ||FQR|| ||
 
|Clonal cytopenias of undetermined significance||Disease|| || || || || ||FQR|| ||
|NEW DISEASE
+
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
 
|NEW (No Prior)
Line 123: Line 123:  
|-
 
|-
 
|Myelodysplastic neoplasm with low blasts and 5q deletion||Disease|| || || || || ||FQR|| ||
 
|Myelodysplastic neoplasm with low blasts and 5q deletion||Disease|| || || || || ||FQR|| ||
|
+
|Myelodysplastic Syndrome (MDS) with Isolated del(5q)
|
+
|Xiaolin Hu, Ph.D; Teresa Smolarek, Ph.D, FACMG
|
+
|Complete
 
|
 
|
 
|
 
|
 
|-
 
|-
 
|Myelodysplastic neoplasm with low blasts and SF3B1 mutation||Disease|| || || || || ||FQR|| ||
 
|Myelodysplastic neoplasm with low blasts and SF3B1 mutation||Disease|| || || || || ||FQR|| ||
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
|Myelodysplastic neoplasm with biallelic TP53 inactivation||Disease|| || || || || ||FQR|| ||
+
|Myelodysplastic neoplasm with biallelic TP53 inactivation||Disease||Eric McGinnis (assigned to new 5th edition page - FQR please follow-up to confirm)|| || || || ||FQR|| ||
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
|
+
|NEW (No Prior)
 
|-
 
|-
 
|Myelodysplastic neoplasm with low blasts||Disease|| || || || || ||FQR|| ||
 
|Myelodysplastic neoplasm with low blasts||Disease|| || || || || ||FQR|| ||